Alnylam Pharmaceuticals (ALNY) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free ALNY Stock Alerts $143.31 -0.40 (-0.28%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSector Gamma AS Sells 20,876 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 27 at 4:38 PMAlnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 52-Week Low at $142.14americanbankingnews.com - April 27 at 5:32 AMOligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™finance.yahoo.com - April 26 at 3:50 PMOligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarketsfinanznachrichten.de - April 26 at 10:49 AMEQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest ratesmarkets.businessinsider.com - April 26 at 1:49 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Reaches New 52-Week Low at $142.14marketbeat.com - April 25 at 3:45 PMAlnylam Pharmaceuticals (ALNY) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - April 25 at 4:32 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock Position Lowered by Handelsbanken Fonder ABmarketbeat.com - April 24 at 6:48 AMDuality Advisers LP Buys 7,682 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 22 at 11:53 AMZurcher Kantonalbank Zurich Cantonalbank Grows Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 21 at 5:43 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Hits New 12-Month Low at $143.50americanbankingnews.com - April 21 at 5:40 AMStockNews.com Downgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Holdamericanbankingnews.com - April 21 at 2:14 AMHow Is The Market Feeling About Alnylam Pharmaceuticals?benzinga.com - April 19 at 4:47 PMAlnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50marketbeat.com - April 19 at 3:27 PMAlnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Resultsbusinesswire.com - April 18 at 8:00 AM3 Biotech Stocks Paving the Way for Bullish Investment Gainsstocknews.com - April 17 at 4:06 PMLevi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNYmarkets.businessinsider.com - April 17 at 10:25 AMMirae Asset Global Investments Co. Ltd. Sells 22,532 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 14 at 5:19 AMAlnylam Pharmaceuticals, Inc. Forecasted to Earn Q1 2024 Earnings of ($1.17) Per Share (NASDAQ:ALNY)marketbeat.com - April 12 at 6:09 AMRegeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinkingbenzinga.com - April 11 at 1:00 PMFY2028 EPS Estimates for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Raised by Analystmarketbeat.com - April 11 at 8:16 AMBuy Rating Affirmed for Alnylam Pharma on Strong Zilebesiran Trial Results and Lucrative Roche Partnershipmarkets.businessinsider.com - April 9 at 6:29 PMBaillie Gifford & Co. Has $1.33 Billion Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 9 at 11:57 AMWegovy Helps HFpEF Patients With Diabetes Mellitusmsn.com - April 8 at 5:27 PMStudy shows promise of zilebesiran injection in reducing systolic blood pressuremsn.com - April 8 at 5:27 PMJefferies Keeps Their Buy Rating on Alnylam Pharma (ALNY)markets.businessinsider.com - April 8 at 5:27 PMWilliam Blair Reaffirms Outperform Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)marketbeat.com - April 8 at 11:37 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by Asset Management One Co. Ltd.marketbeat.com - April 8 at 5:34 AMAlnylam Presents Positive Results From KARDIA-2 Phase 2 Study Of Zilebesiran At ACCmarkets.businessinsider.com - April 7 at 10:19 AMAlnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertensionbusinesswire.com - April 7 at 8:00 AMThose who invested in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago are up 63%finance.yahoo.com - April 6 at 8:46 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Downgraded by StockNews.com to Holdmarketbeat.com - April 5 at 11:10 PMANTIPODES PARTNERS Ltd Has $36.20 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 5 at 4:52 PMAlnylam CEO’s total pay nearly doubles, hitting $8.9Mbizjournals.com - April 5 at 8:54 AMChina Universal Asset Management Co. Ltd. Buys 22,580 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 4 at 6:45 PMPiper Sandler Keeps Their Buy Rating on Sutro Biopharma (STRO)markets.businessinsider.com - April 3 at 11:48 AMPiper Sandler Keeps Their Buy Rating on Aptose Biosciences (APTO)markets.businessinsider.com - April 3 at 11:48 AMAssenagon Asset Management S.A. Raises Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 3 at 4:36 AM$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Todaybenzinga.com - April 2 at 7:33 PMAlnylam Pharmaceuticals (NASDAQ:ALNY) Given "Outperform" Rating at BMO Capital Marketsmarketbeat.com - March 27 at 10:15 AMDecoding 12 Analyst Evaluations For Regeneron Pharmaceuticalsmarkets.businessinsider.com - March 26 at 11:11 AMBuy Rating Affirmed for Alnylam Pharmaceuticals on Strong Commercial Business and Expanding CNS Pipelinemarkets.businessinsider.com - March 25 at 7:27 PMStockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Buymarketbeat.com - March 22 at 11:10 PMAlnylam Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:ALNY)marketbeat.com - March 22 at 1:40 PMAlnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Sessionbusinesswire.com - March 20 at 8:00 AMRapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directorsfinance.yahoo.com - March 19 at 8:34 AMTD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)markets.businessinsider.com - March 19 at 3:34 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by Vanguard Group Inc.marketbeat.com - March 17 at 5:28 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Deutsche Bank AGmarketbeat.com - March 15 at 5:46 AMWellington Management Group LLP Purchases 364,021 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - March 13 at 9:20 AM Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself ALNY Media Mentions By Week ALNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNY News Sentiment▼0.510.32▲Average Medical News Sentiment ALNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNY Articles This Week▼128▲ALNY Articles Average Week Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BioMarin Pharmaceutical News Royalty Pharma News United Therapeutics News Ionis Pharmaceuticals News Madrigal Pharmaceuticals News Genmab A/S News Teva Pharmaceutical Industries News Viatris News BeiGene News Karuna Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNY) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
